Camlin Fine Sciences Moves to Acquire Full Control of Vinpai

Camlin Fine Sciences (CFSL) has submitted a draft tender offer to the French Stock Markets Authority (AMF) aiming to acquire all outstanding shares of its subsidiary, Vinpai. The proposed price is EUR 3.60 per share, matching the rate CFSL paid in its previous acquisition. CFSL currently holds 83.82% of Vinpai's share capital and has decided against a squeeze-out procedure, signaling its intent for full consolidation.

Offer Details and Consolidation Strategy

The filing with the French AMF details CFSL's plan to buy the remaining Vinpai shares at EUR 3.60 each. This price mirrors the amount paid when CFSL initially acquired a 78.68% stake in November 2025. Since then, through the conversion of convertible bonds, CFSL's ownership has grown to 83.82% of Vinpai's share capital and 80.85% of its voting rights. By choosing not to pursue a squeeze-out procedure, CFSL aims to achieve full ownership and consolidate Vinpai's operations. This move is expected to streamline operations, enhance integration benefits, and enable more unified strategic decision-making.

Implications for Shareholders and Vinpai

Vinpai shareholders who still hold shares now have the opportunity to tender them at the specified EUR 3.60 price. Successful completion would allow CFSL to fully integrate Vinpai's financials and operations into its consolidated reporting. The decision against a squeeze-out also means Vinpai could potentially retain its listing on Euronext Growth Paris. Full ownership may unlock further operational synergies and cost efficiencies for the combined entity.

Market Context and Performance

CFSL competes in the food antioxidants and specialty chemicals sector against major players like BASF SE and Archer Daniels Midland (ADM). The company's strategy to fully consolidate Vinpai aims to bolster its position in niche ingredient markets, aligning with industry trends toward integrated supply chains and specialized offerings. In its fiscal year 2025, Vinpai reported revenues of €10.2 million, an increase from €9.2 million in FY2024. However, Vinpai incurred a net loss of €2.876 million for the trailing twelve months.

Risks and Next Steps

The draft tender offer faces several key considerations. It must undergo review and approval by the French AMF. Additionally, the success of the bid hinges on the willingness of Vinpai's remaining minority shareholders to accept the offer. Distribution of offer announcements may also be subject to regulatory restrictions in various countries. Investors will be closely monitoring the AMF's decision, the official offer timetable, and the participation rate of minority shareholders in the coming weeks.